The global facial serum market, valued at $5 billion in 2025, is projected to reach $7.2 billion by 2032 with a CAGR of 5.2%. Growth is fueled by advances in formulation technology, including encapsulation and biotech ingredients, and rising consumer demand for personalized, targeted skincare solutions. Key trends include clean beauty, sustainability, AI-driven customization, and expanding segments like anti-aging and brightening serums. Major players like Amorepacific, L'Oreal, and Johnson & Johnson are leading innovation in this evolving market.
Dividend Aristocrats such as Johnson & Johnson, Coca-Cola, and McDonald's provide reliable and growing passive income through decades of consistent dividend increases. Investing $10,000 in each of these stocks can generate a combined annual passive i...
Johnson & Johnson (JNJ) is seen as having a superior return and risk profile compared to Pfizer (PFE), mainly due to its consistent dividend growth over 63 years, lower payout ratio, ongoing share buybacks, and stable inventory levels. While Pfizer o...
Vanguard High Dividend Yield ETF (VYM) provides retirees with a stable income stream by distributing about 2.9% yield across roughly 540 stocks, minimizing concentration risk. Its portfolio includes large-cap dividend payers like JPMorgan Chase and P...
Johnson & Johnson shares increased 2.58% recently, supported by strong oncology sales and a solid Q1 earnings beat with $24.06 billion revenue and $2.70 EPS. The company raised its full-year revenue and EPS guidance, driven by growth in drugs like DA...
A 66-year-old retiree in Pennsylvania aimed to generate $55,000 annually from a $1.1 million portfolio but lost $2,400 in tax savings because her IRA automatically reinvested dividends shortly after she sold shares at a loss. This triggered the IRS w...
